192 related articles for article (PubMed ID: 24956178)
1. In vitro and in silico studies to explore structural features of flavonoids for aldehyde oxidase inhibition.
Hamzeh-Mivehroud M; Rahmani S; Feizi MA; Dastmalchi S; Rashidi MR
Arch Pharm (Weinheim); 2014 Oct; 347(10):738-47. PubMed ID: 24956178
[TBL] [Abstract][Full Text] [Related]
2. Structure-based investigation of rat aldehyde oxidase inhibition by flavonoids.
Hamzeh-Mivehroud M; Rahmani S; Rashidi MR; Hosseinpour Feizi MA; Dastmalchi S
Xenobiotica; 2013 Aug; 43(8):661-70. PubMed ID: 23282065
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of flavonoids on aldehyde oxidase activity.
Pirouzpanah S; Hanaee J; Razavieh SV; Rashidi MR
J Enzyme Inhib Med Chem; 2009 Feb; 24(1):14-21. PubMed ID: 18608746
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of guinea pig aldehyde oxidase activity by different flavonoid compounds: An in vitro study.
Siah M; Farzaei MH; Ashrafi-Kooshk MR; Adibi H; Arab SS; Rashidi MR; Khodarahmi R
Bioorg Chem; 2016 Feb; 64():74-84. PubMed ID: 26722818
[TBL] [Abstract][Full Text] [Related]
5. Effects of Phenothiazines on Aldehyde Oxidase Activity Towards Aldehydes and N-Heterocycles: an In Vitro and In Silico Study.
Deris-Abdolahpour F; Abdolalipouran-Sadegh L; Dastmalchi S; Hamzeh-Mivehroud M; Zarei O; Dehgan G; Rashidi MR
Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):275-286. PubMed ID: 30382490
[TBL] [Abstract][Full Text] [Related]
6. QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors.
Mercader AG; Pomilio AB
Eur J Med Chem; 2010 May; 45(5):1724-30. PubMed ID: 20116898
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate.
Tan WK; Tan ARY; Sivanandam P; Goh EJH; Yap ZP; Saburulla NF; Austin-Muttitt K; Mullins JGL; Lau AJ
J Pharmacol Exp Ther; 2020 Aug; 374(2):295-307. PubMed ID: 32393528
[TBL] [Abstract][Full Text] [Related]
8. Potent inhibition of human liver aldehyde oxidase by raloxifene.
Obach RS
Drug Metab Dispos; 2004 Jan; 32(1):89-97. PubMed ID: 14709625
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of Ruta graveolens L. extract on guinea pig liver aldehyde oxidase.
Pirouzpanah S; Rashidi MR; Delazar A; Razavieh SV; Hamidi A
Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):9-13. PubMed ID: 16394541
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human aldehyde oxidase activity by diet-derived constituents: structural influence, enzyme-ligand interactions, and clinical relevance.
Barr JT; Jones JP; Oberlies NH; Paine MF
Drug Metab Dispos; 2015 Jan; 43(1):34-41. PubMed ID: 25326286
[TBL] [Abstract][Full Text] [Related]
11. Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase.
Torres RA; Korzekwa KR; McMasters DR; Fandozzi CM; Jones JP
J Med Chem; 2007 Sep; 50(19):4642-7. PubMed ID: 17718551
[TBL] [Abstract][Full Text] [Related]
12. Contribution of aldehyde oxidase, xanthine oxidase, and aldehyde dehydrogenase on the oxidation of aromatic aldehydes.
Panoutsopoulos GI; Kouretas D; Beedham C
Chem Res Toxicol; 2004 Oct; 17(10):1368-76. PubMed ID: 15487898
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of flavonoids on molybdenum hydroxylases activity.
Rashidi MR; Nazemiyeh H
Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):133-52. PubMed ID: 20095789
[TBL] [Abstract][Full Text] [Related]
14. Kinetics and specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase towards substituted benzaldehydes.
Panoutsopoulos GI; Beedham C
Acta Biochim Pol; 2004; 51(3):649-63. PubMed ID: 15448727
[TBL] [Abstract][Full Text] [Related]
15. In Silico and 3D QSAR Studies of Natural Based Derivatives as Xanthine Oxidase Inhibitors.
Malik N; Dhiman P; Khatkar A
Curr Top Med Chem; 2019; 19(2):123-138. PubMed ID: 30727896
[TBL] [Abstract][Full Text] [Related]
16. In Vitro and In Silico Analyses of the Inhibition of Human Aldehyde Oxidase by Bazedoxifene, Lasofoxifene, and Structural Analogues.
Chen S; Austin-Muttitt K; Zhang LH; Mullins JGL; Lau AJ
J Pharmacol Exp Ther; 2019 Oct; 371(1):75-86. PubMed ID: 31289113
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic oxidation of phthalazine with guinea pig liver aldehyde oxidase and liver slices: inhibition by isovanillin.
Panoutsopoulos GI; Beedham C
Acta Biochim Pol; 2004; 51(4):943-51. PubMed ID: 15625566
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductase inhibitors for diabetic complications: Receptor induced atom-based 3D-QSAR analysis, synthesis and biological evaluation.
Vyas B; Singh M; Kaur M; Bahia MS; Jaggi AS; Silakari O; Singh B
J Mol Graph Model; 2015 Jun; 59():59-71. PubMed ID: 25911954
[TBL] [Abstract][Full Text] [Related]
19. Enzyme Kinetics, Pharmacokinetics, and Inhibition of Aldehyde Oxidase.
Paragas EM; Choughule K; Jones JP; Barr JT
Methods Mol Biol; 2021; 2342():257-284. PubMed ID: 34272698
[TBL] [Abstract][Full Text] [Related]
20. QSAR prediction of inhibition of aldose reductase for flavonoids.
Mercader AG; Duchowicz PR; Fernández FM; Castro EA; Bennardi DO; Autino JC; Romanelli GP
Bioorg Med Chem; 2008 Aug; 16(15):7470-6. PubMed ID: 18585047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
